These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24372669)

  • 1. Molecular deficiency (ies) in MT₁ melatonin signaling pathway underlies the melatonin-unresponsive phenotype in MDA-MB-231 human breast cancer cells.
    Mao L; Yuan L; Xiang S; Zeringue SB; Dauchy RT; Blask DE; Hauch A; Hill SM
    J Pineal Res; 2014 Apr; 56(3):246-53. PubMed ID: 24372669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines.
    Treeck O; Haldar C; Ortmann O
    Oncol Rep; 2006 Jan; 15(1):231-5. PubMed ID: 16328061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.
    Mao L; Yuan L; Slakey LM; Jones FE; Burow ME; Hill SM
    Breast Cancer Res; 2010; 12(6):R107. PubMed ID: 21167057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of melatonin anticancer effects.
    Hill SM; Frasch T; Xiang S; Yuan L; Duplessis T; Mao L
    Integr Cancer Ther; 2009 Dec; 8(4):337-46. PubMed ID: 20050373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
    Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
    Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.
    Yuan L; Collins AR; Dai J; Dubocovich ML; Hill SM
    Mol Cell Endocrinol; 2002 Jun; 192(1-2):147-56. PubMed ID: 12088876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin receptor type 1 signals to extracellular signal-regulated kinase 1 and 2 via Gi and Gs dually coupled pathways in HEK-293 cells.
    Chen L; He X; Zhang Y; Chen X; Lai X; Shao J; Shi Y; Zhou N
    Biochemistry; 2014 May; 53(17):2827-39. PubMed ID: 24724723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines.
    Lai L; Yuan L; Cheng Q; Dong C; Mao L; Hill SM
    Breast Cancer Res Treat; 2009 Nov; 118(2):293-305. PubMed ID: 18979234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells.
    González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Mateos S; Hill SM; Sánchez-Barceló EJ; Cos S
    Oncol Rep; 2007 Apr; 17(4):947-53. PubMed ID: 17342341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Galphai and Galphaq proteins mediate the effects of melatonin on steroid/thyroid hormone receptor transcriptional activity and breast cancer cell proliferation.
    Lai L; Yuan L; Chen Q; Dong C; Mao L; Rowan B; Frasch T; Hill SM
    J Pineal Res; 2008 Nov; 45(4):476-88. PubMed ID: 18705646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
    Zhan Y; Zhang Y; Liu C; Zhang J; Smith WW; Wang N; Chen Y; Zheng L; He L
    Cancer Prev Res (Phila); 2012 Jun; 5(6):864-73. PubMed ID: 22496388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin MT1 receptor-induced transcriptional up-regulation of p27(Kip1) in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF-κB): potential implications on prostate cancer chemoprevention and therapy.
    Shiu SY; Leung WY; Tam CW; Liu VW; Yao KM
    J Pineal Res; 2013 Jan; 54(1):69-79. PubMed ID: 22856547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired mouse mammary gland growth and development is mediated by melatonin and its MT1G protein-coupled receptor via repression of ERα, Akt1, and Stat5.
    Xiang S; Mao L; Yuan L; Duplessis T; Jones F; Hoyle GW; Frasch T; Dauchy R; Blask DE; Chakravarty G; Hill SM
    J Pineal Res; 2012 Oct; 53(3):307-18. PubMed ID: 22582905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma.
    Jablonska K; Pula B; Zemla A; Owczarek T; Wojnar A; Rys J; Ambicka A; Podhorska-Okolow M; Ugorski M; Dziegiel P
    J Pineal Res; 2013 Apr; 54(3):334-45. PubMed ID: 23330677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer.
    León J; Casado J; Carazo A; Sanjuán L; Maté A; Muñoz de Rueda P; de la Cueva P; Quiles R; Ruíz S; Ruíz-Extremera A; Salmerón J
    Mol Carcinog; 2012 Aug; 51(8):608-18. PubMed ID: 21809392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting.
    Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G
    Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological, Mechanistic, and Pharmacokinetic Assessment of Novel Melatonin-Tamoxifen Drug Conjugates as Breast Cancer Drugs.
    Hasan M; Marzouk MA; Adhikari S; Wright TD; Miller BP; Matossian MD; Elliott S; Wright M; Alzoubi M; Collins-Burow BM; Burow ME; Holzgrabe U; Zlotos DP; Stratford RE; Witt-Enderby PA
    Mol Pharmacol; 2019 Aug; 96(2):272-296. PubMed ID: 31221824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation.
    Jawed S; Kim B; Ottenhof T; Brown GM; Werstiuk ES; Niles LP
    Eur J Pharmacol; 2007 Mar; 560(1):17-22. PubMed ID: 17303109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antitumor activity of melatonin receptor agonists.
    Mao L; Cheng Q; Guardiola-Lemaître B; Schuster-Klein C; Dong C; Lai L; Hill SM
    J Pineal Res; 2010 Oct; 49(3):210-21. PubMed ID: 20609073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.